Skip to main content

Advertisement

Table 1 Demographic characteristics and prevalence of metabolic disorders

From: Age- and gender-specific population attributable risks of metabolic disorders on all-cause and cardiovascular mortality in Taiwan

Characteristics (%) Men (n = 2092) Death Women (n = 2197) Death p-valuec
   All-cause (n = 167) CVD (n = 42)   All-cause (n = 91) CVD (n = 32)  
Age (yrs.)        0.0001
30-45 920 (44.0) 16 (9.6) 6 (14.3) 1054 (48.0) 13 (14.3) 1 (3.1)  
45-55 533 (25.5) 28 (16.8) 5 (11.9) 598 (27.2) 15 (16.5) 3 (9.4)  
≥ 55 639 (30.5) 123 (73.7) 31 (73.8) 545 (24.8) 63 (69.2) 28 (87.5)  
BMIa (kg/m²)        < 0.0001
< 18.5 56 (2.7) 10 (6.0) 1 (2.7) 125 (5.7) 9 (9.9) 3 (10.3)  
18.5-24.9 1273 (60.9) 107 (64.1) 25 (67.6) 1500 (68.3) 48 (52.8) 18 (62.1)  
25-29.9 ≥ 679 (32.5) 44 (26.4) 9 (24.3) 479 (21.8) 28 (30.8) 8 (27.6)  
30 84 (4.0) 6 (3.6) 2 (5.4) 93 (4.2) 6 (6.6) 0 (0.0)  
BMIb (kg/m²)        < 0.0001
< 18.5 56 (2.7)9 10 (6.0) 1 (2.4) 125 (5.7) 9 (9.9) 3 (9.4)  
18.5-24 78 (46.8) 84 (50.3) 19 (45.2) 1279 (58.2) 39 (42.9) 16 (50.0)  
24-27 708 (33.8) 57 (34.1) 15 (35.7) 528 (24.0) 25 (27.5) 9 (28.1)  
≥ 27 350 (16.7) 16 (9.6) 7 (16.7) 265 (12.1) 18 (19.8) 4 (12.5)  
Alcohol drinking 982 (46.9) 65 (38.9) 13 (31.0) 258 (11.7) 10 (11.0) 3 (9.4) < 0.0001
Smoking 1116 (53.4) 104 (62.3) 24 (57.1) 85 (3.9) 9 (9.9) 3 (9.4) < 0.0001
Betel nut chewing 660 (31.6) 57 (34.1) 16 (38.1) 61 (2.8) 5 (5.5) 2 (6.3) < 0.0001
Excercise 1076 (51.4) 90 (53.9) 23 (54.8) 1204 (54.8) 42 (46.2) 12 (37.5) 0.03
Education        < 0.0001
Less than elementary school 550 (26.3) 94 (56.3)53 (31.7) 20 (12.0) 24 (57.1)13 (31.0)5 (11.9) 811 (37.0)996 (45.4)388 (17.7) 69 (75.8)19 (20.9) 3 (3.3) 27 (84.4) 5 (15.6) 0 (0.0)  
High school diploma 996 (47.6)       
More than high school 546 (26.1)       
Marital status        < 0.0001
Married 1804 (86.3) 133 (79.6) 34 (81.0)1 (2.4)3 (7.1)4 (9.5) 1780 (81.0) 87 (4.0) 216 (9.8) 114 (5.2) 49 (53.9) 4 (4.4) 37 (40.7) 1 (1.1) 15 (46.9) 1 (3.1)16 (50.0) 0 (0.0)  
Divorced or separated 54 (2.5) 4 (2.4)      
Widower or widow/Living together Single 60 (2.8)
174 (8.4)
16 (9.6)
14 (8.4)
     
Income        < 0.0001
No income 228 (10.9) 44 (26.5) 10 (23.8) 760 (34.7) 47 (51.7) 19 (59.4)  
Less than 10,000 NTD 197 (9.5) 33 (19.9) 9 (21.4) 263 (12.0) 27 (29.7) 12 (37.5)  
10,000-40,000 NTD 888 (42.6) 63 (38.0) 18 (42.9) 886 (40.5) 14 (15.4) 1 (3.1)  
More than 40,000 NTD 772 (37.0) 26 (15.7) 5 (11.9) 281 (12.8) 3 (3.3) 0 (0.0)  
Self-reported CVD 277 (13.3) 47 (28.1) 19 (45.2) 290 (13.2) 36 (40.0) 18 (58.1) 0.9667
MetS 467 (22.3) 58 (34.7) 24 (57.1) 347 (15.8) 39 (42.9) 20 (62.5) < 0.0001
High WC 702 (33.6) 64 (38.3) 21 (50.0) 742 (33.8) 56 (61.5) 25 (78.1) 0.88
AH 596 (28.5) 94 (56.3) 32 (76.2) 422 (19.2) 50 (55.0) 20 (62.5) < 0.0001
DM 188 (9.0) 35 (21.0) 16 (38.1) 147 (6.7) 22 (24.2) 11 (34.4)  
HighTG 464 (22.2) 35 (21.0) 13 (31.0) 241 (11.0) 20 (22.0) 11 (34.4) < 0.0001
Low HDL-C 479 (22.9) 50 (29.9) 15 (35.7) 522 (23.8) 25 (27.5) 17 (53.1) 0.50
  1. a: BMI classification according to the recommended standard of the WHO
  2. b: BMI classification according to the recommended standard of the Taiwan
  3. Department of Health
  4. c: Significance level of two sample t-test or chi-squared test for the difference in gender
  5. 1BMI, body mass index; DM, diabetes mellitus; AH, arterial hypertension; HDL-C, high-density lipoprotein cholesterol; MetS, metabolic syndrome; NTD, New Taiwan Dollar; TG, triglycerides; WC, waist circumference
  6. 2Central obesity was defined as WC ≥ 90 cm in men and ≥ 80 cm in women; AH was defined as an average SBP of ≥ 140 mmHg, DBP of ≥ 90 mmHg, or treatment for previously diagnosed AH; DM was defined as a FPG ≥ 126 mg/dL (7 mmol/L) or use of insulin or other hypoglycemic agents; High TG was defined as a serum triacylglycerol concentration ≥ 200 mg/dL (2.26 mmol/L); Low HDL-C was defined as a HDL-C < 40 mg/dL (1.03 mmol/L) in men and < 50 mg/dL (1.29 mmol/L) in women; The (modified) NCEP MetS was defined as having at least three of the following: (1) WC ≥ 90 cm in men and ≥ 80 cm in women; (2) SBP ≥ 130 mmHg, DBP ≥ 85 mmHg, or self-reported treatment with antihypertensive medications; (3) FPG ≥ 110 mg/dL (6.1 mmol/L) or use of insulin or hypoglycemic agents; (4) serum TG ≥ 150 mg/dL (1.7 mmol/L); (5) low HDL-C